Scientists tested whether anaplastic lymphoma kinase AL2 (ALKAL2) ligand could potentiate neuroblastoma progression in the absence of ALK mutation
[EMBO Journal]
6807162 {6807162:AM7GLK5W} apa 50 1 157723 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-b438f14b56c59ebbbdc73b89b5c4c0fd%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22AM7GLK5W%22%2C%22library%22%3A%7B%22id%22%3A6807162%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Boren%5Cu00e4s%20et%20al.%22%2C%22parsedDate%22%3A%222021-01-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBoren%26%23xE4%3Bs%2C%20M.%2C%20Umapathy%2C%20G.%2C%20Lai%2C%20W.-Y.%2C%20Lind%2C%20D.%20E.%2C%20Witek%2C%20B.%2C%20Guan%2C%20J.%2C%20Mendoza-Garcia%2C%20P.%2C%20Masudi%2C%20T.%2C%20Claeys%2C%20A.%2C%20Chuang%2C%20T.-P.%2C%20El%20Wakil%2C%20A.%2C%20Arefin%2C%20B.%2C%20Fransson%2C%20S.%2C%20Koster%2C%20J.%2C%20Johansson%2C%20M.%2C%20Gaarder%2C%20J.%2C%20Van%20den%20Eynden%2C%20J.%2C%20Hallberg%2C%20B.%2C%20%26amp%3B%20Palmer%2C%20R.%20H.%20%282021%29.%20ALK%20ligand%20ALKAL2%20potentiates%20MYCN-driven%20neuroblastoma%20in%20the%20absence%20of%20ALK%20mutation.%20%3Ci%3EThe%20EMBO%20Journal%3C%5C%2Fi%3E%2C%20%3Ci%3En%5C%2Fa%3C%5C%2Fi%3E%28n%5C%2Fa%29%2C%20e105784.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.15252%5C%2Fembj.2020105784%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.15252%5C%2Fembj.2020105784%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6807162%26amp%3Bitem_key%3DAM7GLK5W%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22ALK%20ligand%20ALKAL2%20potentiates%20MYCN-driven%20neuroblastoma%20in%20the%20absence%20of%20ALK%20mutation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcus%22%2C%22lastName%22%3A%22Boren%5Cu00e4s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ganesh%22%2C%22lastName%22%3A%22Umapathy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei-Yun%22%2C%22lastName%22%3A%22Lai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dan%20E%22%2C%22lastName%22%3A%22Lind%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Witek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jikui%22%2C%22lastName%22%3A%22Guan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Mendoza-Garcia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tafheem%22%2C%22lastName%22%3A%22Masudi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arne%22%2C%22lastName%22%3A%22Claeys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tzu-Po%22%2C%22lastName%22%3A%22Chuang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abeer%22%2C%22lastName%22%3A%22El%20Wakil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Badrul%22%2C%22lastName%22%3A%22Arefin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susanne%22%2C%22lastName%22%3A%22Fransson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%22%2C%22lastName%22%3A%22Koster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathias%22%2C%22lastName%22%3A%22Johansson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennie%22%2C%22lastName%22%3A%22Gaarder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jimmy%22%2C%22lastName%22%3A%22Van%20den%20Eynden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bengt%22%2C%22lastName%22%3A%22Hallberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruth%20H%22%2C%22lastName%22%3A%22Palmer%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%20High-risk%20neuroblastoma%20%28NB%29%20is%20responsible%20for%20a%20disproportionate%20number%20of%20childhood%20deaths%20due%20to%20cancer.%20One%20indicator%20of%20high-risk%20NB%20is%20amplification%20of%20the%20neural%20MYC%20%28MYCN%29%20oncogene%2C%20which%20is%20currently%20therapeutically%20intractable.%20Identification%20of%20anaplastic%20lymphoma%20kinase%20%28ALK%29%20as%20an%20NB%20oncogene%20raised%20the%20possibility%20of%20using%20ALK%20tyrosine%20kinase%20inhibitors%20%28TKIs%29%20in%20treatment%20of%20patients%20with%20activating%20ALK%20mutations.%208%3F10%25%20of%20primary%20NB%20patients%20are%20ALK-positive%2C%20a%20figure%20that%20increases%20in%20the%20relapsed%20population.%20ALK%20is%20activated%20by%20the%20ALKAL2%20ligand%20located%20on%20chromosome%202p%2C%20along%20with%20ALK%20and%20MYCN%2C%20in%20the%20%3F2p-gain%3F%20region%20associated%20with%20NB.%20Dysregulation%20of%20ALK%20ligand%20in%20NB%20has%20not%20been%20addressed%2C%20although%20one%20of%20the%20first%20oncogenes%20described%20was%20v-sis%20that%20shares%20%3E%5Cu00a090%25%20homology%20with%20PDGF.%20Therefore%2C%20we%20tested%20whether%20ALKAL2%20ligand%20could%20potentiate%20NB%20progression%20in%20the%20absence%20of%20ALK%20mutation.%20We%20show%20that%20ALKAL2%20overexpression%20in%20mice%20drives%20ALK%20TKI-sensitive%20NB%20in%20the%20absence%20of%20ALK%20mutation%2C%20suggesting%20that%20additional%20NB%20patients%2C%20such%20as%20those%20exhibiting%202p-gain%2C%20may%20benefit%20from%20ALK%20TKI-based%20therapeutic%20intervention.%22%2C%22date%22%3A%22January%207%2C%202021%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.15252%5C%2Fembj.2020105784%22%2C%22ISSN%22%3A%220261-4189%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.embopress.org%5C%2Fdoi%5C%2Ffull%5C%2F10.15252%5C%2Fembj.2020105784%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-01-08T20%3A44%3A16Z%22%7D%7D%5D%7D
Borenäs, M., Umapathy, G., Lai, W.-Y., Lind, D. E., Witek, B., Guan, J., Mendoza-Garcia, P., Masudi, T., Claeys, A., Chuang, T.-P., El Wakil, A., Arefin, B., Fransson, S., Koster, J., Johansson, M., Gaarder, J., Van den Eynden, J., Hallberg, B., & Palmer, R. H. (2021). ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation. The EMBO Journal, n/a(n/a), e105784. https://doi.org/10.15252/embj.2020105784 Cite